Clinical trials: Major Depression Disorder
Major Depression
Risperidone Augmentation Therapy in Patients Who Have Failed or Only Partially Responded to a Trial of Antidepressant
The purpose of this study is to assess the safety and efficacy of risperidone augmentation in patients who have failed to respond or only partially responded to an adequate trial of an antidepressant.
- Trial name
- NCT00174577
- Testing
- Risperidone
- Where
- 2 sites in United States
- Volunteers
- 84 people
- Sponsor
- Rhode Island Hospital